Latka logo
Orano Med logo

Orano Medrevenue

Plano, TexasFounded 2009CEO Eric Goode

Orano Med seeks to develop a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb). The company specializes in developing cancer-fighting isotopes for radioimmunotherapy and has a portfolio of biological targets.

oranomed.comLinkedInUpdated Sep 10, 2026
Annual revenue
$38M
Sep 2025EST
Employees
196
Sep 2025

Orano Med revenue

Orano Med has not published its revenue. Growjo puts it at about $38M a year (September 2025).

$0
$10M
$20M
$30M
$0
–
$38M
20092010–242025
ReportedEstimateFounded 2009 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$38MESTGrowjo estimate

Orano Med CEO & employees

Eric Goode is CEO of Orano Med. Orano Med has 196 employees (September 2025, LinkedIn).

0
50
100
150
196
2025
ReportedOne figure per year; a reported figure wins over an estimate

Orano Med FAQ

What is Orano Med's revenue?

Growjo estimates Orano Med's revenue at about $38M a year (September 2025). The company hasn't published its own figure.

How many employees does Orano Med have?

Orano Med has 196 employees as of September 2025, according to LinkedIn.

Who is the CEO of Orano Med?

Eric Goode is the CEO of Orano Med.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Orano Med? Join the podcast